Partnering with Skyepharma

Patient using an inhaler

Inhalation Drug Development
Expert capabilities
and enabling technologies

Patient consuming medicine in tablet form

Oral Modified Release
A long track record
and validated technologies


Skyepharma’s success is built on partnering with pharmaceutical companies and applying our expert inhalation and oral drug delivery capabilities.

We welcome the opportunity to explore potential collaboration with companies of all sizes, either by the application of our capabilities and technologies to our partners’ products or for licensing of our own products or technologies.

Applying our technologies and capabilities to make your drugs better

With 14 products currently approved that incorporate our technologies, we bring a wealth of knowledge know-how and our inhalation and oral drug delivery technologies to support the product development or Life Cycle Management strategies of our partners.

We provide a full range of product development services from formulation development to scale-up, through clinical trial supplies and regulatory submissions to commercial manufacturing and supply. Throughout this process, we work with our partners to provide the required drug delivery performance and product profile as part of an integrated project plan.

Licensing opportunities

We welcome the opportunity to discuss the licensing of our products or technologies.

Contact us if you are interested in discussing potential collaboration with Skyepharma.

Copyright 2014, Skyepharma. All Rights Reserved. Skyepharma PLC is a public limited company registered in England and Wales, registration number 0107582.
Registered office: 46-48 Grosvenor Gardens, London SW1W 0EB, United Kingdom

Contact addresses

Skyepharma PLC
46-48 Grosvenor Gardens
London
SW1W 0EB
UK

Tel: +44 207 881 0524

Fax: +44 207 881 1199

E-mail us

Skyepharma AG
Eptingerstrasse 61
4132 Muttenz
Switzerland

Tel: +41 61 467 5555

Fax: +41 61 467 5500

E-mail us

This website works best using cookies.